Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE
Por um escritor misterioso
Descrição
Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24‐week treatment‐free follow‐up - Desrosiers - International Forum of Allergy & Rhinology - Wiley Online Library
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect
Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study - Aikaterini Detoraki, Eugenio Tremante, Maria D'Amato, Cecilia Calabrese, Claudia
Mepolizumab effective for chronic rhinosinusitis with nasal polyps despite comorbidities
PDF] Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count - ScienceDirect
JPM, Free Full-Text
Comorbidity Data NUCALA (mepolizumab) for HCPs
PDF] Chronic Rhinosinusitis with Nasal Polyps.
Mepolizumab Induced Loss of Smell Improvement in Patients With Chronic Rhinosinusitis With Nasal Polyps From the SYNAPSE Study
de
por adulto (o preço varia de acordo com o tamanho do grupo)
